Hartman Institute for Therapeutic Organ Regeneration

Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration.

TitlePlatelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration.
Publication TypeJournal Article
Year of Publication2015
AuthorsRafii S, Cao Z, Lis R, Siempos II, Chavez D, Shido K, Rabbany SY, Ding B-S
JournalNat Cell Biol
Volume17
Issue2
Pagination123-136
Date Published2015 Feb
ISSN1476-4679
KeywordsAnimals, Antigens, CD, Blood Platelets, Cadherins, Capillaries, Chemokine CXCL12, Endothelial Cells, Epidermal Growth Factor, Gene Deletion, Ligands, Matrix Metalloproteinase 14, Mice, Organ Specificity, Platelet Membrane Glycoprotein IIb, Pneumonectomy, Pulmonary Alveoli, Receptor, Fibroblast Growth Factor, Type 1, Receptors, CXCR, Receptors, CXCR4, Regeneration, Signal Transduction, Thrombopoietin, Vascular Endothelial Growth Factor Receptor-2
Abstract

<p>The lung alveoli regenerate after surgical removal of the left lobe by pneumonectomy (PNX). How this alveolar regrowth/regeneration is initiated remains unknown. We found that platelets trigger lung regeneration by supplying stromal-cell-derived factor-1 (SDF-1, also known as CXCL12). After PNX, activated platelets stimulate SDF-1 receptors CXCR4 and CXCR7 on pulmonary capillary endothelial cells (PCECs) to deploy the angiocrine membrane-type metalloproteinase MMP14, stimulating alveolar epithelial cell (AEC) expansion and neo-alveolarization. In mice lacking platelets or platelet Sdf1, PNX-induced alveologenesis was diminished. Reciprocally, infusion of Sdf1(+/+) but not Sdf1-deficient platelets rescued lung regeneration in platelet-depleted mice. Endothelial-specific ablation of Cxcr4 and Cxcr7 in adult mice similarly impeded lung regeneration. Notably, mice with endothelial-specific Mmp14 deletion exhibited impaired expansion of AECs but not PCECs after PNX, which was not rescued by platelet infusion. Therefore, platelets prime PCECs to initiate lung regeneration, extending beyond their haemostatic contribution. Therapeutic targeting of this haemo-vascular niche could enable regenerative therapy for lung diseases.</p>

DOI10.1038/ncb3096
Alternate JournalNat Cell Biol
PubMed ID25621952
PubMed Central IDPMC4886751
Grant ListR01 HL115128 / HL / NHLBI NIH HHS / United States
R01HL097797 / HL / NHLBI NIH HHS / United States
U54CA163167 / CA / NCI NIH HHS / United States
U54 CA163167 / CA / NCI NIH HHS / United States
R01 HL128158 / HL / NHLBI NIH HHS / United States
R01 DK095039 / DK / NIDDK NIH HHS / United States
R01HL128158 / HL / NHLBI NIH HHS / United States
R01 HL097797 / HL / NHLBI NIH HHS / United States
R01HL119872 / HL / NHLBI NIH HHS / United States
R01DK095039 / DK / NIDDK NIH HHS / United States
R01 HL119872 / HL / NHLBI NIH HHS / United States
R01HL115128 / HL / NHLBI NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065